This comprehensive review maps how endogenous opioid peptides (endorphins, enkephalins, dynorphins, endomorphins, nociceptin) regulate chronic pain through distinct receptor systems, informing targeted analgesic development.
Multiple pain targets5 opioid peptide families acting through 4 receptor types offer numerous targets for developing safer, pathway-specific chronic pain treatments
What the researchers found
Endogenous opioid peptides operate through distinct mu, delta, kappa, and NOP receptor systems with unique distribution and function in chronic pain conditions, offering multiple targets for developing targeted, safer analgesics.
Why it matters
The opioid crisis demands better pain treatments. Understanding which endogenous opioid pathways are involved in which pain types enables development of targeted analgesics without the addiction risk of non-selective opioids.
How the study worked
Comprehensive review covering opioid peptide biogenesis, anatomical distribution, receptor pharmacology, roles in chronic pain states, and therapeutic implications.
What this study cannot tell us
Comprehensive but written before some recent advances in opioid pharmacogenomics and biased agonism. Not all proposed therapeutic strategies have been clinically validated.
How to read the evidence
Moderate to strong evidence from a comprehensive review integrating decades of opioid peptide and pain research.
When this study was published
Published in 2001. The endogenous opioid system's role in pain continues to guide analgesic drug development, with biased agonists and peripheral opioids now in clinical trials.
The bigger picture
Moving from one-size-fits-all opioid drugs to targeted, pathway-specific analgesics could provide effective pain relief without the addiction, tolerance, and respiratory depression that plague current treatment.
Questions still open
- Can pathway-selective opioid drugs be developed for specific pain types?
- Does endogenous opioid system dysfunction cause chronic pain?
- Could combination opioid receptor targeting provide synergistic analgesia?
Common questions
Why not just use stronger opioid drugs for chronic pain?
What are the body's natural painkillers?
Read the original research
Opioids in chronic pain.
European journal of pharmacology, 429(1-3), 79-91
Citation
Przewłocki, R; Przewłocka, B. (2001). Opioids in chronic pain.. European journal of pharmacology, 429(1-3), 79-91.